Sanjivani Paranteral reports Q3 FY26 earnings call; targets FY27 revenue around INR 150–155 crores with injectables driving growth, aided by the IV facility expansion; margins supported by product mix.
AI Assistant
Sanjivani Paranteral Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.